iRhythm Technologies (IRTC)
(Delayed Data from NSDQ)
$164.97 USD
+24.79 (17.68%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $164.74 -0.23 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
IRTC 164.97 +24.79(17.68%)
Will IRTC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IRTC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRTC
iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth
IRTC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will iRhythm Technologies (IRTC) Report Negative Earnings Next Week? What You Should Know
Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
Other News for IRTC
iRhythm Technologies (IRTC) Surges Over 15%
JP Morgan Raises iRhythm Technologies (IRTC) Price Target to $190 | IRTC Stock News
IRTC Stock Sees Target Price Raised by Canaccord Genuity | IRTC Stock News
Oppenheimer Boosts iRhythm (IRTC) Price Target Following Strong Q2 Results
Wells Fargo Raises Price Target for iRhythm Technologies (IRTC) to $180 | IRTC Stock News